These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 33941611)
1. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299 [TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
4. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling. Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775 [TBL] [Abstract][Full Text] [Related]
5. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. Deng J; Kang Y; Cheng CC; Li X; Dai B; Katz MH; Men T; Kim MP; Koay EA; Huang H; Brekken RA; Fleming JB JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34237033 [TBL] [Abstract][Full Text] [Related]
6. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774 [No Abstract] [Full Text] [Related]
8. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150 [TBL] [Abstract][Full Text] [Related]
9. KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Yang J; Jin L; Kim HS; Tian F; Yi Z; Bedi K; Ljungman M; Pasca di Magliano M; Crawford H; Shi J Cancer Res; 2022 Nov; 82(22):4247-4260. PubMed ID: 36306422 [TBL] [Abstract][Full Text] [Related]
11. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells. Li J; Ke J; Fang J; Chen JP J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239 [TBL] [Abstract][Full Text] [Related]
12. EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of Patil S; Steuber B; Kopp W; Kari V; Urbach L; Wang X; Küffer S; Bohnenberger H; Spyropoulou D; Zhang Z; Versemann L; Bösherz MS; Brunner M; Gaedcke J; Ströbel P; Zhang JS; Neesse A; Ellenrieder V; Singh SK; Johnsen SA; Hessmann E Cancer Res; 2020 Nov; 80(21):4620-4632. PubMed ID: 32907838 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma. Wang H; Yu S; Peng H; Shu Y; Zhang W; Zhu Q; Wu Y; Xu Y; Yan J; Xiang H J Exp Clin Cancer Res; 2020 Oct; 39(1):216. PubMed ID: 33054826 [TBL] [Abstract][Full Text] [Related]
15. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618 [TBL] [Abstract][Full Text] [Related]
16. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. D'Costa Z; Jones K; Azad A; van Stiphout R; Lim SY; Gomes AL; Kinchesh P; Smart SC; Gillies McKenna W; Buffa FM; Sansom OJ; Muschel RJ; O'Neill E; Fokas E Cancer Res; 2017 Nov; 77(21):5952-5962. PubMed ID: 28765154 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]